# Trauma-Pharma #3: bug juice in open fractures with Alex Smithers Page: https://stenobird.com/podcast/trauma-ing-7049449/trauma-pharma-3-bug-juice-in-open-fractures-with-alex-smithers Text version: https://stenobird.com/podcast/trauma-ing-7049449/trauma-pharma-3-bug-juice-in-open-fractures-with-alex-smithers.md Podcast: [TRAUMA-ING](https://stenobird.com/podcast/trauma-ing-7049449) Published: 2025-05-22T17:14:28+00:00 Episode link: https://www.trauma-ing.com/podcast/trauma-pharma-3-bug-juice-in-open-fractures-with-alex-smithers Audio file: https://static1.squarespace.com/static/66ec702b0012414ab9214ef3/t/682f5afcc8d61a78ef130abb/1747933971203/011+Trauma-Pharma+%233+bug+juice+for+open+fractures.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/trauma-ing-7049449/episodes/trauma-pharma-3-bug-juice-in-open-fractures-with-alex-smithers Duration seconds: 837 ## Resource In this episode of Trauma-ing, clinical pharmacist Alex Smithers joins us to break down antibiotic management for open fractures. We cover the go-to use of cefazolin, then dig into how antibiotic choices shift based on patient risk factors and the Gustilo-Anderson classification. A practical, case-based discussion for anyone involved in the early management of traumatic injuries. For more FOAM trauma related content head to www.trauma-ing.com ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/trauma-ing-7049449/episodes/trauma-pharma-3-bug-juice-in-open-fractures-with-alex-smithers/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/trauma-ing-7049449/trauma-pharma-3-bug-juice-in-open-fractures-with-alex-smithers.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.